These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1092 related items for PubMed ID: 11113839

  • 21. Reproductive axis after discontinuation of gonadotropin-releasing hormone analog treatment of girls with precocious puberty: long term follow-up comparing girls with hypothalamic hamartoma to those with idiopathic precocious puberty.
    Feuillan PP, Jones JV, Barnes K, Oerter-Klein K, Cutler GB.
    J Clin Endocrinol Metab; 1999 Jan; 84(1):44-9. PubMed ID: 9920060
    [Abstract] [Full Text] [Related]

  • 22. Long-term effectiveness of depot gonadotropin-releasing hormone analogue in the treatment of children with central precocious puberty.
    Clemons RD, Kappy MS, Stuart TE, Perelman AH, Hoekstra FT.
    Am J Dis Child; 1993 Jun; 147(6):653-7. PubMed ID: 8506834
    [Abstract] [Full Text] [Related]

  • 23. Short-term treatment of idiopathic precocious puberty with a long-acting analogue of luteinizing hormone-releasing hormone. A preliminary report.
    Comite F, Cutler GB, Rivier J, Vale WW, Loriaux DL, Crowley WF.
    N Engl J Med; 1981 Dec 24; 305(26):1546-50. PubMed ID: 6458765
    [Abstract] [Full Text] [Related]

  • 24. Reproductive hormones and hypothalamic-pituitary-ovarian axis in female patients with homozygous beta-thalassemia major.
    Safarinejad MR.
    J Pediatr Hematol Oncol; 2010 May 24; 32(4):259-66. PubMed ID: 20445415
    [Abstract] [Full Text] [Related]

  • 25. Responsivity of pituitary gonadotropes to luteinizing hormone-releasing factor in idiopathic precocious puberty, precocious thelarche, precocious adrenarche, and in patients treated with medroxyprogesterone acetate.
    Reiter EO, Kaplan SL, Conte FA, Grumbach MM.
    Pediatr Res; 1975 Feb 24; 9(2):111-6. PubMed ID: 1090891
    [Abstract] [Full Text] [Related]

  • 26. Time to menarche and final height after histrelin implant treatment for central precocious puberty.
    Gillis D, Karavani G, Hirsch HJ, Strich D.
    J Pediatr; 2013 Aug 24; 163(2):532-6. PubMed ID: 23485026
    [Abstract] [Full Text] [Related]

  • 27. Gonadotropin-releasing hormone testing in premature thelarche.
    Choubtum L, Mahachoklertwattana P, Sriphrapradang A, Preeyasombat C.
    J Med Assoc Thai; 1999 Nov 24; 82 Suppl 1():S33-8. PubMed ID: 10730515
    [Abstract] [Full Text] [Related]

  • 28. Final height outcome after three years of growth hormone and gonadotropin-releasing hormone agonist treatment in short adolescents with relatively early puberty.
    van Gool SA, Kamp GA, Visser-van Balen H, Mul D, Waelkens JJ, Jansen M, Verhoeven-Wind L, Delemarre-van de Waal HA, de Muinck Keizer-Schrama SM, Leusink G, Roos JC, Wit JM.
    J Clin Endocrinol Metab; 2007 Apr 24; 92(4):1402-8. PubMed ID: 17284626
    [Abstract] [Full Text] [Related]

  • 29. Bone mineral content in girls with precocious puberty treated with gonadotropin-releasing hormone analog.
    Verrotti A, Chiarelli F, Montanaro AF, Morgese G.
    Gynecol Endocrinol; 1995 Dec 24; 9(4):277-81. PubMed ID: 8629454
    [Abstract] [Full Text] [Related]

  • 30. Does GnRH analog improve the final height in Thai girls with idiopathic central precocious puberty?
    Wacharasindhu S, Srivuthana S, Aroonparkmongkol S, Trinavarat P.
    J Med Assoc Thai; 2001 Jun 24; 84 Suppl 1():S51-6. PubMed ID: 11529380
    [Abstract] [Full Text] [Related]

  • 31. [Clinical study of subcutaneous administration of gonadotropin-releasing hormone agonist every six weeks in girls with idiopathic central precocious puberty].
    Liang Y, Wei H, Zhang JL, Hou L, Luo XP.
    Zhonghua Er Ke Za Zhi; 2004 Nov 24; 42(11):845-9. PubMed ID: 15631714
    [Abstract] [Full Text] [Related]

  • 32. Adult height in girls with idiopathic true precocious puberty.
    Brauner R, Adan L, Malandry F, Zantleifer D.
    J Clin Endocrinol Metab; 1994 Aug 24; 79(2):415-20. PubMed ID: 8045957
    [Abstract] [Full Text] [Related]

  • 33. Sexual precocity in boys: accelerated versus slowly progressive puberty gonadotropin-suppressive therapy and final height.
    Lazar L, Pertzelan A, Weintrob N, Phillip M, Kauli R.
    J Clin Endocrinol Metab; 2001 Sep 24; 86(9):4127-32. PubMed ID: 11549638
    [Abstract] [Full Text] [Related]

  • 34. Efficacy of subcutaneous administration of gonadotropin-releasing hormone agonist on idiopathic central precocious puberty.
    Liang Y, Wei H, Zhang J, Hou L, Luo X.
    J Huazhong Univ Sci Technolog Med Sci; 2006 Sep 24; 26(5):558-61. PubMed ID: 17219967
    [Abstract] [Full Text] [Related]

  • 35. Leptin changes in Taiwanese girls with central precocious puberty before and during the GnRH agonist treatment.
    Su PH, Wang SL, Lin CY, Chen JY, Changlai CP, Jian SH, Chen SJ.
    Acta Paediatr Taiwan; 2005 Sep 24; 46(5):278-83. PubMed ID: 16640001
    [Abstract] [Full Text] [Related]

  • 36. [Impact of gonadotropin-releasing hormone analogs on body mass index in girls with idiopathic central precocious puberty: a long-term follow-up study].
    Yuan JN, Liang L, Cai XD, Li Z, Bai M, Gu CP.
    Zhongguo Dang Dai Er Ke Za Zhi; 2011 Nov 24; 13(11):896-9. PubMed ID: 22099200
    [Abstract] [Full Text] [Related]

  • 37. Treatment of central precocious puberty.
    Kaplowitz PB.
    Curr Opin Endocrinol Diabetes Obes; 2009 Feb 24; 16(1):31-6. PubMed ID: 19104235
    [Abstract] [Full Text] [Related]

  • 38. Clinical use of the LH-RH in assessing gonadotropic reserve in children with idiopathic precocious puberty, premature thelarche and premature adrenarche.
    Sanchez F, Forsbach G, Zarate A, Canales ES, Soria J, Angers M.
    Arch Invest Med (Mex); 1976 Feb 24; 7(3):123-6. PubMed ID: 797330
    [Abstract] [Full Text] [Related]

  • 39. Prolonged vaginal bleeding during central precocious puberty therapy with a long-acting gonadotropin-releasing hormone agonist.
    Yeshaya A, Kauschansky A, Orvieto R, Varsano I, Nussinovitch M, Ben-Rafael Z.
    Acta Obstet Gynecol Scand; 1998 Mar 24; 77(3):327-9. PubMed ID: 9539281
    [Abstract] [Full Text] [Related]

  • 40. The histrelin implant: a novel treatment for central precocious puberty.
    Hirsch HJ, Gillis D, Strich D, Chertin B, Farkas A, Lindenberg T, Gelber H, Spitz IM.
    Pediatrics; 2005 Dec 24; 116(6):e798-802. PubMed ID: 16322137
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 55.